CD68 and neoplasm: In agreement with the in vitro data, Vidatox promotes tumor growth as demonstrated by increased tumor volume and high Ki-67 labelled growth fraction in rat HCCs without affecting innate immunity evaluated by CD8, CD56 and CD68 expression.